A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient

Journal of Pharmaceutical and Biomedical Analysis

Volumn 58, Issue 1, 2012, Pages 136-140

  Thomas, Saji ^a   Shandilya, Sanjeev ^a   Bharti, Amber ^a   Agarwal, Ashutosh ^a  

^a Jubilant Life Sciences Ltd   (India)

Author keywords

Fampridine; Impurity; Stress study; Validation

Indexed keywords

2 AMINOPYRIDINE; 3 AMINOPYRIDINE; 4 AMINOPYRIDINE; ISONICOTINAMIDE; NICOTINIC ACID;

ACCURACY; ARTICLE; DENSITY GRADIENT; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INSTRUMENT VALIDATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET RADIATION;

4-AMINOPYRIDINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG CONTAMINATION; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; OXIDATION-REDUCTION; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RAYS;

EID: 80255138052     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.09.009     Document Type: Article

References (8)

1. Reynolds J.E.F. Martindale the Complete Drug Reference 2008, Royal Pharmaceutical Society of Great Britain, p. 574. 35th ed.
2. Hayes K.C., Potter P.J., Hsieh J.T., Katz M.A., Blight A.R., Cohen R. Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Arch. Phy. Med. Rehabil. 2004, 85:29-34.
3. Vollmer T., Henney H.R. Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a phase I-II, open-label trial. Clin. Ther. 2009, 31:2206-2210.
4. Vollmer T., Blight A.R., Henney H.R. Steady-state pharmacokinetics a tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study. Clin. Ther. 2009, 31:2215-2223.
5. Donnelly R.F. Chemical stability of 4-aminopyridine capsules. Can. J. Hospital Pharm. 2004, 57:284-287.
6. ICH Guidelines, Stability testing of new drug substances and drug products: text and methodology Q1 A (R2), February 2003.
7. ICH Guidelines, Validation of analytical procedures stability testing of new drug substances and drug products: text and methodology Q2 (R1), November 2005.
8. ICH Guidelines, Impurities in new drug substances Q3A (R2), October 2006.